IRONWOOD PHARMACEUTICALS INC·4

Mar 7, 4:05 PM ET

MCCOURT Thomas A 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Mar 7, 2024

Insider Transaction Report

Form 4
Period: 2024-03-05
MCCOURT Thomas A
DirectorChief Executive Officer
Transactions
  • Award

    Performance-based Restricted Stock Unit

    2024-03-05+132,438132,438 total
    Exp: 2027-02-28Class A Common Stock (132,438 underlying)
  • Award

    Class A Common Stock

    2024-03-05+264,8761,097,650 total
Footnotes (2)
  • [F1]The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
  • [F2]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4